Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported that preclinical ...
Given the chokehold they had on audiences earlier, that their comeback would be so embroiled in turmoil and controversies was something fans and, more importantly, Chester Bennington's family did not ...
Lineage, Inc., a high-tech cold-storage REIT, had a successful IPO with strong investor demand, but its current valuation appears overly expensive. The company leverages advanced data science and ...